Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0386
-0.0004 (-1.03%)
Aug 1, 2025, 4:00 PM EDT
Zomedica Revenue
Zomedica had revenue of $6.50M in the quarter ending March 31, 2025, with 3.80% growth. This brings the company's revenue in the last twelve months to $27.52M, up 6.00% year-over-year. In the year 2024, Zomedica had annual revenue of $27.29M with 8.33% growth.
Revenue (ttm)
27.52M
Revenue Growth
+6.00%
P/S Ratio
1.38
Revenue / Employee
181.07K
Employees
152
Market Cap
37.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.29M | 2.10M | 8.33% |
| Dec 31, 2023 | 25.19M | 6.26M | 33.05% |
| Dec 31, 2022 | 18.93M | 14.80M | 358.02% |
| Dec 31, 2021 | 4.13M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Zomedica News
- 16 days ago - Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets - Accesswire
- 22 days ago - Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala - Accesswire
- 5 weeks ago - Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope - Accesswire
- 6 weeks ago - Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics - Accesswire
- 2 months ago - Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution - Accesswire
- 2 months ago - Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations - Accesswire
- 2 months ago - Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth - Accesswire
- 2 months ago - Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy - Accesswire